2023 Generic Medicine Pharmaceutical Manufacturing 
Quality Matters
JANUARY 23, 2023
They include steps championed by USP and others to increase supply chain visibility, support advanced drug manufacturing technologies, and bolster federal health agencies for the benefit of patients and public health. USP looks forward to working with all stakeholders on implementation of these important initiatives in 2023.
Express Pharma
NOVEMBER 15, 2024
Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in It meets the healthcare needs of over 1.4
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Quality Matters
APRIL 18, 2024
Importantly, these efforts can provide USP Convention Member organizations and Expert Volunteers with even more transparency on the impact we are collectively making to improve global public health, bolster environmental sustainability of the pharmaceutical supply chain, and build trust in science-based institutions like USP.
Quality Matters
MAY 18, 2023
Coburn spotlighted four related objectives: Increasing manufacturing flexibility while maintaining quality and accountability; improving supply chain visibility; increasing redundancies in suppliers and decreasing supply chain length; and modernizing and optimizing stockpiling. kristine.gates… Thu, 05/18/2023 - 10:42 Supply Chain
Quality Matters
SEPTEMBER 15, 2023
For example, while some stakeholders may perceive PCM to be primarily for innovators and not for makers of generic medicines or biotech companies, it “can be for generic companies, biotechnology companies, and so on, and we have had engagements with generic drug companies in our emerging technologies program already,” Fisher said.
Pharmaceutical Technology
DECEMBER 19, 2022
in 2022 to 1% in 2023 due to the “tightening of monetary and financial conditions”. Furthermore, for months, several financial institutions such as Bank of America and JP Morgan have been talking of a “mild recession” in 2023 for the US. by the end of 2023 and may continue to rise in 2024 to 5%.
Expert insights. Personalized for you.
52 
Let's personalize your content